Statistics for Kiniksa Pharmaceuticals Ltd (id:7861 KNSA)

Valuation metrics

Market cap

1.53B

Enterprise value

1.29B

Trailing P/E (ttm)

164.31

Forward P/E

38.56

PEG ratio

38.56

Price/Sales (ttm)

3.99

Price/Book (mrq)

3.50

Enterprise Value/Revenue

3.36

Enterprise Value/EBITDA

-52.87

Overview

Shares outstanding

41.57M

Float

15.29M

Shares short

4.21M

% Held by insiders

0.04%

% Held by institutions

0.98%

Average volume (10 days)

297.62K

Average volume (90 days)

Price summary

52-Week low

15.52

52-Week high

28.15

52-Week change

24.70%

Beta

0.35

50-Day moving average

24.57

200-Day moving average

21.78

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-2.36%

Operating margin

-8.61%

Operational effectiveness

Return on assets

-3.16%

Return on equity

-2.15%

Income statement

Revenue (ttm)

5.42

Revenue per share (ttm)

5.42

Quarterly revenue growth (yoy)

Gross profit (ttm)

236.85M

EBITDA

-24,401,000.00

Net income to common (ttm)

-9,068,000.00

Diluted EPS (ttm)

-0.12

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

223.78M

Total cash per share (mrq)

3.10

Total debt (mrq)

10.60M

Total Debt/Equity (mrq)

2.42

Current ratio (mrq)

324.40%

Book value per share (mrq)

6.06

Cash flow

Cash flow statement

11.24M

Levered free cash flow (LFCF)

25.74M